Form D · Other
Celeri Health, Inc.
Wilmington, DE · CIK 0001769327
Offering snapshot reported Jan 26, 2022 · SEC filing
- Reported sold
- $2M Offering amount: $2M
- Investors reported
- 2 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Jan 14, 2022 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jan 26, 2022 | Initial | $2,000,000 | No comparison | 2 | SEC filing |
| Mar 6, 2019 | Initial | $50,000 | No comparison | 1 | SEC filing |
Offering details
- Securities
- Equity, Debt, Security to be acquired
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-430830
Source: Form D, filed Jan 26, 2022. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Neal Bibeau | Director |
| Jon Brillant | Director, Executive |
| Michael Fishman | Director, Executive |
| Sean Mc Crossen | Director, Executive |
| Robin Sullivan | Director |
| David Tannenbaum | Director, Executive |
Issuer details
Industry: Other (See others in industry)
Address:
1815 W. 13th Street, Suite 5
Wilmington, DE, 19806
Wilmington, DE, 19806